Exploring New Therapeutic Options for Alcohol Use Disorder

This chapter explores a promising new study on the combination therapy of prazosin and cyproheptadine for treating alcohol use disorder. It highlights how this approach addresses neurotransmitter imbalances and shows significant improvements in alcohol consumption among participants, particularly benefiting those with co-occurring PTSD symptoms.